Kiwa Bio-Tech Products Group Corporation (KWBT) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Kiwa Bio-Tech Products Group Corporation (KWBT) stock?
Kiwa Bio-Tech Products Group Corporation (KWBT) no longer trades on public markets. The figures below are historical and are not a current quote.
Beta 2.91: the stock has moved about 191% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Kiwa Bio-Tech Products Group Corporation (KWBT). Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes bio-technological products for the agricultural market, primarily in China. The company focuses on bio-fertilizers to improve crop yields and soil health. Sector: Basic materials.
Last analyzed: Mar 17, 2026Analyst Coverage for KWBT: KWBT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KWBT against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
KWBT: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Kiwa Bio-Tech Products Group Corporation (KWBT) Materials & Commodity Exposure
Kiwa Bio-Tech Products Group Corporation focuses on developing and distributing bio-fertilizers in the Chinese agricultural market, leveraging strategic partnerships and proprietary technology to offer sustainable solutions for crop yield enhancement and soil health, operating within a competitive landscape of both domestic and international players.
What Is the Investment Thesis for KWBT?
Kiwa Bio-Tech Products Group Corporation presents a focused play on the growing demand for bio-fertilizers in China. The company's strategic partnerships with research institutions and its range of bio-fertilizer products position it to capitalize on the increasing adoption of sustainable agricultural practices. However, the company's negative profit margin of -16.6% and lack of dividend payments raise concerns about its financial stability. The high beta of 2.91 suggests significant volatility. Future growth hinges on successful product commercialization, expansion of distribution networks, and effective management of operational costs. Investors should closely monitor the company's ability to achieve profitability and generate positive cash flow.
Based on FMP financials and quantitative analysis
KWBT Key Highlights
Kiwa Bio-Tech operates in the agricultural inputs sector, focusing on bio-fertilizers.
- The company's products include bacillus species-based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers.
- Kiwa Bio-Tech has strategic cooperation agreements with several agricultural research institutions in China.
- The company's gross margin is 23.3%.
- The company's profit margin is -16.6%.
Who Are KWBT's Competitors?
KWBT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AGRZ Agroz Inc. | $0.24 | -5.38% | $5.14M | 505-pillar |
| SEED Origin Agritech Limited | $1.05 | +3.96% | $12.7M | — |
| ARLSF Argo Graphene Solutions Corp. | $0.70 | +0.78% | $17.7M | 449-signal |
| BIOX Bioceres Crop Solutions Corp. | $0.42 | -0.91% | $26.7M | 385-pillar |
| BHST BioHarvest Sciences Inc. | $1.85 | -1.07% | $32.1M | — |
| AVD American Vanguard Corporation | $2.24 | +0.45% | $64.1M | 365-pillar |
| IPI Intrepid Potash, Inc. | $40.28 | -2.38% | $541M | 845-pillar |
| BWEL JG Boswell Company | $594.00 | -0.17% | $573M | 549-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are KWBT's Key Strengths?
Proprietary bio-fertilizer technology
- Strategic partnerships with research institutions
- Established presence in the Chinese market
- Focus on sustainable agriculture
What Are KWBT's Weaknesses?
Negative profit margin
- Limited financial resources
- Dependence on the Chinese market
- Small number of employees
What Could Drive KWBT Stock Higher?
Increasing demand for bio-fertilizers in China due to environmental concerns and government support.
- Strategic partnerships with research institutions to develop innovative products.
- Potential expansion into new geographic markets within China.
- Development and launch of new bio-fertilizer products targeting specific crops.
- Government subsidies and incentives for sustainable agriculture practices.
What Are the Key Risks for KWBT?
Financial-distress signal — its Altman Z-Score of 1.21 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-59.2%) — the business is not currently generating profit on shareholder capital.
- Competition from larger agricultural companies with greater resources.
- Fluctuations in raw material prices affecting production costs.
- Changes in government regulations impacting the bio-fertilizer industry.
- Economic slowdown in China reducing demand for agricultural products.
- Limited financial resources and negative profit margin.
What Are the Growth Opportunities for KWBT?
- Expansion of Product Line: Kiwa Bio-Tech can expand its product line to include a wider range of bio-fertilizers and related agricultural products. This could involve developing new formulations, targeting specific crops, or addressing specific soil conditions. The market for specialized bio-fertilizers is growing, as farmers seek tailored solutions for their needs. This expansion could increase revenue streams and market share, with a potential market size of $5 billion by 2030.
- Geographic Expansion within China: Kiwa Bio-Tech can expand its geographic reach within China, targeting regions with high agricultural activity and a growing demand for bio-fertilizers. This could involve establishing new distribution partnerships, opening regional offices, or participating in agricultural trade shows. The Chinese agricultural market is vast and diverse, offering significant opportunities for growth. This expansion could increase sales volume and brand awareness, with a timeline of 3-5 years.
- Strategic Partnerships and Acquisitions: Kiwa Bio-Tech can pursue strategic partnerships and acquisitions to enhance its technological capabilities, expand its product portfolio, or gain access to new markets. This could involve collaborating with research institutions, acquiring smaller bio-fertilizer companies, or partnering with agricultural distributors. Strategic alliances can accelerate growth and create synergies, with ongoing opportunities.
- Increased Focus on Research and Development: Kiwa Bio-Tech can increase its investment in research and development to develop innovative bio-fertilizer products and improve existing formulations. This could involve conducting field trials, collaborating with universities, or hiring experienced scientists. Innovation is crucial for maintaining a competitive edge in the bio-fertilizer market, with a continuous timeline.
- Government Support and Subsidies: Kiwa Bio-Tech can leverage government support and subsidies for the development and adoption of bio-fertilizers. The Chinese government is actively promoting sustainable agriculture and providing financial incentives for farmers to use environmentally friendly products. This support can reduce costs and increase demand for Kiwa Bio-Tech's products, with ongoing opportunities.
What Are KWBT's Competitive Advantages?
- Proprietary bio-fertilizer formulations
- Strategic partnerships with research institutions
- Established distribution network in China
- Brand recognition in the Chinese agricultural market
What Does KWBT Do?
Kiwa Bio-Tech Products Group Corporation, established in 2002 and headquartered in Yangling, China, is dedicated to the development, manufacturing, and distribution of bio-technological products tailored for the agricultural sector. The company's core offerings include a range of bio-fertilizers, encompassing bacillus species-based biological organic fertilizers, compound microbial fertilizers, bio-water soluble fertilizers, and microbial inoculum fertilizers. These products are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. Kiwa Bio-Tech has strategically aligned itself with key institutions such as the Beijing Zhongpin Agricultural Science and Technology Development Center, the China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and the Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. These collaborations facilitate research, development, and market access within the Chinese agricultural landscape. The company's focus on bio-fertilizers addresses the growing demand for environmentally friendly agricultural solutions in China, driven by increasing awareness of soil degradation and the need for sustainable farming practices.
What Products and Services Does KWBT Offer?
- Develops bio-technological products for the agricultural market.
- Manufactures bio-fertilizers.
- Markets bio-fertilizers.
- Distributes bio-fertilizers.
- Offers bacillus species-based biological organic fertilizers.
- Offers compound microbial fertilizers.
- Offers bio-water soluble fertilizers.
- Offers microbial inoculum fertilizers.
How Does KWBT Make Money?
- Develops and manufactures bio-fertilizers.
- Sells bio-fertilizers to distributors and farmers.
- Generates revenue through product sales.
- Forms strategic partnerships for research and development.
What Industry Does KWBT Operate In?
Kiwa Bio-Tech operates within the agricultural inputs industry, specifically focusing on the bio-fertilizer segment. The Chinese agricultural sector is undergoing a shift towards sustainable practices, driven by government regulations and increasing awareness of environmental concerns. The market for bio-fertilizers is growing, as farmers seek alternatives to traditional chemical fertilizers. Kiwa Bio-Tech competes with both domestic and international players in this space. The industry is characterized by technological innovation, product differentiation, and the need for strong distribution networks to reach farmers across China.
Who Are KWBT's Key Customers?
- Farmers in China
- Agricultural distributors
- Agricultural cooperatives
- Large-scale agricultural operations
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 51 |
| 2026-08-24 | 51 |
| 2026-08-25 | 51 |
| 2026-08-26 | 51 |
What changed?
The score has stayed at 51.
Over the same 3 days the stock moved +0.0%.
Company Profile
Kiwa Bio-Tech Products Group Corporation operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Yangling, CN. The company is led by CEO Ziqi Wang. KWBT has traded publicly since 2002.
Key Financial Metrics
Return on equity for Kiwa Bio-Tech Products Group Corporation stands at -59.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.6%, showing how much profit it generates from its asset base. A current ratio of 1.60 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Kiwa Bio-Tech Products Group Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.21 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 7 insider filings for Kiwa Bio-Tech Products Group Corporation break down as 2 sales and 5 purchases. On net that is roughly 3.1M shares acquired (about $28.2M) — insiders putting money in tends to read as conviction.
KWBT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary bio-fertilizer technology
- Strategic partnerships with research institutions
- Established presence in the Chinese market
- Focus on sustainable agriculture
Bear Case
- Negative profit margin
- Limited financial resources
- Dependence on the Chinese market
- Small number of employees
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KWBT Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Feb 27, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Nov 26, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Nov 20, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Nov 5, 2019
Leadership: Ziqi Wang
CEO
Ziqi Wang serves as the CEO of Kiwa Bio-Tech Products Group Corporation. Further research would be needed to provide a comprehensive background.
Track Record: Due to limited information, Ziqi Wang's key achievements, strategic decisions, and company milestones under their leadership cannot be accurately assessed. Additional data is required to evaluate their track record effectively.
KWBT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Kiwa Bio-Tech Products Group Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited regulatory oversight and potentially higher risks compared to companies listed on major exchanges or higher OTC tiers. This tier often includes companies with distressed financials, early-stage ventures, or those that choose not to comply with stricter listing standards.
- OTC Tier: OTC Other
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Higher risk of fraud or mismanagement
- Lack of regulatory oversight
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Strategic partnerships with reputable organizations
- Positive media coverage or industry recognition
- Experienced management team
- Clear business plan and growth strategy
- Audited financial statements (if available)
Common Questions About KWBT (Basic Materials)
What happened to Kiwa Bio-Tech Products Group Corporation (KWBT) stock?
Kiwa Bio-Tech Products Group Corporation (KWBT) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy KWBT shares?
No. KWBT stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for KWBT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KWBT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kiwa Bio-Tech Products Group Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Kiwa Bio-Tech Products Group Corporation do?
Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes a range of bio-fertilizers for the agricultural market, primarily in China.
What do analysts say about KWBT stock?
As of 2026-03-17, there is no available analyst coverage or consensus on Kiwa Bio-Tech Products Group Corporation (KWBT). The company's market capitalization is $0.00B, and it trades on the OTC market.
What are the main risks for KWBT?
Kiwa Bio-Tech Products Group Corporation faces several risks, including competition from larger agricultural companies, fluctuations in raw material prices, and changes in government regulations.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market carries inherent risks due to lower regulation and liquidity.